ArticleOncotarget2019

AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer.

Marie-Anne Goyette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.